| 2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the … A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ... Annals of the rheumatic diseases 79 (6), 713-723, 2020 | 795 | 2020 |
| Lupus nephritis HJ Anders, R Saxena, M Zhao, I Parodis, JE Salmon, C Mohan Nature reviews Disease primers 6 (1), 7, 2020 | 746 | 2020 |
| EULAR recommendations for the management of systemic lupus erythematosus: 2023 update A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ... Annals of the rheumatic diseases 83 (1), 15-29, 2024 | 301 | 2024 |
| B cell alterations during BAFF inhibition with belimumab in SLE D Ramsköld, I Parodis, T Lakshmikanth, N Sippl, M Khademi, Y Chen, ... EBioMedicine 40, 517-527, 2019 | 116 | 2019 |
| Smoking and pre-existing organ damage reduce the efficacy of belimumab in systemic lupus erythematosus I Parodis, C Sjöwall, A Jönsen, D Ramsköld, A Zickert, M Frodlund, ... Autoimmunity reviews 16 (4), 343-351, 2017 | 109 | 2017 |
| Cardiovascular disease in systemic lupus erythematosus: recent data on epidemiology, risk factors and prevention M Kostopoulou, D Nikolopoulos, I Parodis, G Bertsias Current Vascular Pharmacology 18 (6), 549-565, 2020 | 103 | 2020 |
| Prediction of prognosis and renal outcome in lupus nephritis I Parodis, F Tamirou, FA Houssiau Lupus science & medicine 7 (1), e000389, 2020 | 101 | 2020 |
| B cell therapy in systemic lupus erythematosus: from rationale to clinical practice I Parodis, M Stockfelt, C Sjöwall Frontiers in Medicine 7, 316, 2020 | 69 | 2020 |
| The CD6/ALCAM pathway promotes lupus nephritis via T cell–mediated responses SA Chalmers, RA Ramachandran, SJ Garcia, E Der, L Herlitz, J Ampudia, ... The Journal of Clinical Investigation 132 (1), 2022 | 65 | 2022 |
| Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis I Parodis, C Adamichou, S Aydin, A Gomez, N Demoulin, ... Rheumatology 59 (11), 3424-3434, 2020 | 59 | 2020 |
| COVID-19 vaccination in autoimmune disease (COVAD) survey protocol P Sen, L Gupta, JB Lilleker, V Aggarwal, S Kardes, M Milchert, T Gheita, ... Rheumatology international 42 (1), 23-29, 2022 | 56 | 2022 |
| Interferon (IFN)-λ is a potential mediator in lupus nephritis A Zickert, V Oke, I Parodis, E Svenungsson, Y Sundström, I Gunnarsson Lupus science & medicine 3 (1), e000170, 2016 | 56 | 2016 |
| ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus I Parodis, S Gokaraju, A Zickert, K Vanarsa, T Zhang, D Habazi, J Botto, ... Rheumatology 59 (9), 2237-2249, 2020 | 50 | 2020 |
| Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following … I Parodis, A Zickert, B Sundelin, M Axelsson, J Gerhardsson, ... Lupus science & medicine 2 (1), e000061, 2015 | 47 | 2015 |
| Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus I Parodis, P Johansson, A Gomez, S Soukka, S Emamikia, ... Rheumatology 58 (12), 2170-2176, 2019 | 45 | 2019 |
| COVAD survey 2 long-term outcomes: unmet need and protocol ZZ Fazal, P Sen, M Joshi, N Ravichandran, JB Lilleker, V Agarwal, ... Rheumatology international 42 (12), 2151-2158, 2022 | 44 | 2022 |
| Adverse health-related quality of life outcome despite adequate clinical response to treatment in systemic lupus erythematosus A Gomez, V Qiu, A Cederlund, A Borg, J Lindblom, S Emamikia, Y Enman, ... Frontiers in Medicine 8, 651249, 2021 | 43 | 2021 |
| Biologics in SLE: towards new approaches RF van Vollenhoven, I Parodis, A Levitsky Best Practice & Research Clinical Rheumatology 27 (3), 341-349, 2013 | 43 | 2013 |
| EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis I Parodis, C Girard-Guyonvarc’h, L Arnaud, O Distler, A Domján, ... Annals of the Rheumatic Diseases 83 (6), 720-729, 2024 | 42 | 2024 |
| Fatigue in systemic lupus erythematosus: an update on its impact, determinants and therapeutic management L Kawka, A Schlencker, P Mertz, T Martin, L Arnaud Journal of Clinical Medicine 10 (17), 3996, 2021 | 42 | 2021 |
